NanoRibo

NanoRibo was founded in May 2021 as a biopharmaceutical technology company focused on the research and development of novel vaccines/drugs in the field of mRNA-related technologies. The founding team has over 20 years of accumulated experience in virology and vaccines, along with R&D and industrialization expertise in the mRNA field from leading overseas MNCs. They have held key positions in top research institutions and MNCs both domestically and internationally, truly mastering the core know-how of the mRNA field.